169 related articles for article (PubMed ID: 14636362)
1. Antidepressant monotherapy for bipolar type II major depression.
Amsterdam JD; Brunswick DJ
Bipolar Disord; 2003 Dec; 5(6):388-95. PubMed ID: 14636362
[TBL] [Abstract][Full Text] [Related]
2. Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate.
Amsterdam JD; Shults J; Brunswick DJ; Hundert M
Bipolar Disord; 2004 Feb; 6(1):75-81. PubMed ID: 14996144
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
Amsterdam JD; Shults J
J Affect Disord; 2005 Jul; 87(1):121-30. PubMed ID: 15923042
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.
Amsterdam JD; Shults J
Int Clin Psychopharmacol; 2005 Sep; 20(5):257-64. PubMed ID: 16096516
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine monotherapy in women with bipolar II and unipolar major depression.
Amsterdam JD; Garcia-España F
J Affect Disord; 2000 Sep; 59(3):225-9. PubMed ID: 10854639
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
Amsterdam JD; Garcia-España F; Fawcett J; Quitkin FM; Reimherr FW; Rosenbaum JF; Schweizer E; Beasley C
J Clin Psychopharmacol; 1998 Dec; 18(6):435-40. PubMed ID: 9864074
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode.
Amsterdam J
J Clin Psychopharmacol; 1998 Oct; 18(5):414-7. PubMed ID: 9790160
[TBL] [Abstract][Full Text] [Related]
8. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
9. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder.
Gao K; Kemp DE; Ganocy SJ; Muzina DJ; Xia G; Findling RL; Calabrese JR
Bipolar Disord; 2008 Dec; 10(8):907-15. PubMed ID: 19594506
[TBL] [Abstract][Full Text] [Related]
10. [Olanzapine: a second generation antipsychotic drug and an "atypical" mood stabilizer?].
Bánki CM
Psychiatr Hung; 2007; 22(4):311-20. PubMed ID: 18167425
[TBL] [Abstract][Full Text] [Related]
11. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
[TBL] [Abstract][Full Text] [Related]
12. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
13. Suicide risk and choice of antidepressant.
Davis A; Gilhooley M; Agius M; Zaman R
Psychiatr Danub; 2010 Jun; 22(2):358-9. PubMed ID: 20562782
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant options: venlafaxine in perspective.
Thase ME
J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):10S-18S; discussion 18S-20S. PubMed ID: 8784644
[TBL] [Abstract][Full Text] [Related]
15. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
Entsuah AR; Huang H; Thase ME
J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
[TBL] [Abstract][Full Text] [Related]
16. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP;
Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639
[TBL] [Abstract][Full Text] [Related]
17. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
Thase ME; Entsuah AR; Rudolph RL
Br J Psychiatry; 2001 Mar; 178():234-41. PubMed ID: 11230034
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of antidepressant's use in the treatment of depressive episodes in bipolar disorder - review of research.
Antosik-Wójcińska AZ; Stefanowski B; Święcicki Ł
Psychiatr Pol; 2015; 49(6):1223-39. PubMed ID: 26909398
[TBL] [Abstract][Full Text] [Related]
19. [Trazodone and venlafaxine in treatment of depressive disorders].
Florkowski A; Gruszczyński W; Gałecki P; Zboralski K; Kołodziejska I; Mikołajczyk I
Pol Merkur Lekarski; 2005 May; 18(107):556-9. PubMed ID: 16161955
[TBL] [Abstract][Full Text] [Related]
20. Venlafaxine: a 2003 update.
Gutierrez MA; Stimmel GL; Aiso JY
Clin Ther; 2003 Aug; 25(8):2138-54. PubMed ID: 14512125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
